Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd.

Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd. was established in 2010 and is located in China Pharmaceutical City, Taizhou, Jiangsu. The company has a registered capital of 85 million yuan. At present, it has invested nearly 200 million yuan to build a workshop including APIs (general APIs and anti-tumor APIs); Sterile freeze-dried preparation workshop (general freeze-drying and anti-tumor freeze-drying); oral solid preparation workshop (general medicine and anti-tumor drug); small volume injection workshop (terminal sterilization); fully equipped production line, with a workshop area of 12,000 Square meters, the company has more than 100 R&D and production personnel.

The company has various analysis and testing instruments such as high-performance liquid phase, gas phase, infrared, ultraviolet, dissolution apparatus, osmotic pressure analyzer, insoluble particle analyzer, moisture analyzer, etc. The main instruments have audit tracking functions to ensure the authenticity of data and traceable. Nanjing Perfect Pharmaceutical Technology Co., Ltd. is a R&D subsidiary controlled by Jiangsu Huatai Chenguang Pharmaceutical Co., Ltd. It is located in "Jiangsu Life Science and Technology Park", Qixia District, Nanjing City, Jiangsu Province. It has a R&D laboratory of nearly 2,000 square meters and has 20 main R&D technicians. many people.

In recent years, the company has applied for nearly 20 new drugs and generic drugs, 9 anesthetic and psychotropic drug project approvals, 5 clinical approvals, and 3 production approvals. Among them, the small-volume injection workshop, the second raw material workshop, and the first workshop for oral solid preparations have passed the GMP compliance inspection.

The company is mainly committed to the exploration and research of high-barrier generic drugs such as perioperative and tumor analgesic drugs for sperm and anesthesia control. At the same time, with the help of the world's leading new drug delivery technology, the company develops improved new drugs with significant technological progress and application prospects. Provide more and better drug choices.